A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and in Combination with Pembrolizumab in Subjects with KRASG12C Mutant Advanced Solid Tumors - Projekt - Autoren - KSSG Forschungsdatenbank

Projekt

A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and in Combination with Pembrolizumab in Subjects with KRASG12C Mutant Advanced Solid Tumors

Laufend - Rekrutierung – laufend · 2022 bis 2027

Weindler Susanne, Donno Monica, Quinter Janine

Weindler, Susanne

Oberärztin
Medizinische Onkologie und Hämatologie · Dept. I

Donno, Monica

Studienkoordinator/in
Medizinische Onkologie und Hämatologie · Dept. I

Quinter, Janine

Medizinische Onkologie und Hämatologie · Dept. I